142
Views
11
CrossRef citations to date
0
Altmetric
Research Article

Dicloxacillin: A Higher Risk than Cloxacillin for Infusion Phlebitis

, &
Pages 397-400 | Published online: 08 Jul 2009

References

  • Lanbeck P, Odenholt I, Paulsen O. Antibiotics differ in their tendency to cause infusion phlebitis: a prospective observational study. Scand J Infect Dis 2002; 34: 512–9.
  • Ehringer H, Fischer M, Holzner JH, Imhof H, Kubiena K, Lechner K, et al. Gangran nach versehentlicher intrarterieller injektion von dicloxacillin. Dtsch Med Wochenschr 1971; 96: 1127–30.
  • Gottlob R. Endotelschadigungen durch intravasale injektionen von arzneimitteln. Arzneimittelforschung 1972; 22: 1970–5.
  • Sinapius D, Bründel K-H. Endothelschadigung durch die halbsyntetischen penicilline cloxacillin, dicloxacillin und flukloxacillin. Vasa 1975; 4: 54–8.
  • Lewis GB, Hecker JF. Infusion thrombophlebitis. Br J Anaesth 1985; 57: 220–33.
  • Maki DG, Ringer M. Risk factors for infusion-related phlebitis with small peripheral venous catheters. A randomized controlled trial. Ann Intern Med 1991; 114: 845–54.
  • Cornely OA, Bethe U, Pauls R, Waldschmidt D. Peripheral Teflon catheters: factors determining incidence of phlebitis and duration of cannulation. Infect Control Hosp Epidemiol 2002; 23: 249–53.
  • Roberts GW, Holmes MD, Staugas RE, Day RA, Finlay CF, Pitcher A. Peripheral intravenous line survival and phlebitis prevention in patients receiving intravenous antibiotics: heparin/hydrocortisone versus in-line filters. Ann Pharmacother 1994; 28: 11–6.
  • Thomas ET, Evers W, Racz GB. Postinfusion phlebitis. Anesth Analg 1970; 49: 150–9.
  • The Swedish Association of the Pharmaceutical Industry (LIF), Stockholm. Pharmacological Specialities in Sweden 2002. Elanders: Kungsbacka; 2002.
  • Marcy SM, Klein JO. The isoxazolyl penicillins: oxacillin, cloxacillin and dicloxacillin. Med Clin North Am 1970; 54: 1127–43.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.